GHK-Cu, the copper peptide: topical use, evidence and limits
GHK-Cu is a small peptide of three amino acids bound to copper. It appears in skin care products and, increasingly, in compounded creams and serums. The evidence is modest and mostly cosmetic. This page separates the topical form, which pharmacies may prepare, from the injected form, which they may not.
Information current as of November 10, 2026. Educational only. Confirm everything here with your own clinician before starting, stopping or changing any medication.
At a glance
What it is
A tripeptide, glycyl-histidyl-lysine, bound to a copper ion.
What it is used for
Topical products aimed at skin appearance. These are not FDA-approved uses.
What the evidence shows
A small randomized trial after laser resurfacing found no objective improvement but higher satisfaction. Reviews describe mostly lab and cosmetic data.
Topical form
On the FDA’s interim Category 1 list for non-injectable routes.
Injected form
Withdrawn from consideration. Summit does not prescribe it.
What is next
The FDA has said it plans to consult its advisory committee before the end of February 2027.
Uses
What GHK-Cu is used for
GHK-Cu is used mainly on the skin. Products are sold for skin texture, the look of fine lines and the healing of skin after procedures. Some people use it on the scalp. None of these is an FDA-approved use for a drug. Cosmetic products make claims without drug-level testing.
A physician-prescribed compounded cream is a different product from a cosmetic serum. The prescription is for a named patient, prepared by a licensed pharmacy. That does not mean it has been shown to work, and Dr. Miranda says so at the visit.
For hair loss with the strongest evidence, see minoxidil and finasteride.
How it works
How GHK-Cu is thought to work
GHK is a fragment of a protein found in blood plasma, and it binds copper tightly. In lab studies it affects genes involved in tissue repair and collagen. Most of this work is in cells and animals.
Applied to the skin, only a small amount gets past the surface. Delivery methods such as microneedling are studied for that reason, and microneedling carries its own risks and is a separate decision.
Evidence
What the studies show
The best human evidence is small. A randomized trial in 13 patients tested topical GHK-Cu after carbon dioxide laser resurfacing. There was no objective improvement, though patients reported higher satisfaction. A review of the research describes most of the work as laboratory and cosmetic studies.
A 2026 systematic review has also looked at microneedle approaches in this area. In plain terms, the human data are few and small, and nothing here shows GHK-Cu changes aging or disease. Individual results vary, and trials in different populations are not directly comparable.
Safety
Side effects and cautions
On the skin, GHK-Cu can cause redness, dryness or irritation, and allergic contact reactions are possible. People with copper-related conditions such as Wilson disease should not use copper products without their specialist.
Call your physician for
- A rash that spreads or blisters
- Swelling of the face or lips
- Skin that looks infected, with warmth, pus or fever
About the injected form
Injectable GHK-Cu is not on the FDA’s list of substances pharmacies may compound. Products sold online for injection are not prepared under that policy, and Summit does not prescribe them.
Before you start
Questions worth asking before using a copper peptide
Ask what the product is for. If the goal is the look of the skin, the honest comparison is with ingredients that have long human records, such as sunscreen and prescription retinoids, which a dermatologist can discuss. GHK-Cu would be an extra, not a replacement.
Ask who is making it and how it is labeled. A prescription product from a licensed pharmacy lists what is in it and in what form. Many items sold online as copper peptide are cosmetics, or are sold for injection, and are not made under the FDA’s interim policy for pharmacies.
Ask how you will judge it. Take a clear photo in the same light before you start, and review it with the physician after a set period. Because the one small trial found higher satisfaction without objective improvement, your own opinion will matter, and a photo keeps that opinion honest.
Ask about the rules changing. The FDA has said it will consult its advisory committee about this substance, so the pharmacy route that exists today may change. Dr. Miranda will tell you if it does. For thinning hair, the minoxidil page shows what has better trial support.
Regulatory status
GHK-Cu and pharmacies
On the FDA’s interim list, GHK-Cu is in Category 1 for non-injectable routes only. The injectable route was withdrawn from the nominations. Category 1 means the FDA does not intend to take action against pharmacies that compound it under section 503A while it reviews the substance. The FDA has said it plans to consult its Pharmacy Compounding Advisory Committee before the end of February 2027, so this status can change.
Compounded drugs are not FDA-approved. The FDA does not evaluate them for safety, effectiveness or quality before they are sold.
Summit’s role
What Summit does with GHK-Cu
Dr. Miranda prescribes GHK-Cu after a physician evaluation. Only a non-injectable preparation is considered, made by an independent, state-licensed pharmacy for you as a named patient. Summit does not dispense or sell it, and it keeps no stock in the office.
Nothing on this page promises a prescription. If GHK-Cu does not fit your history, labs and goals, you will hear why. See pricing for what the program includes, including labs.
Common questions
Questions people ask
Is GHK-Cu FDA-approved?
No. It appears on the FDA’s interim Category 1 list for non-injectable routes only, which allows pharmacy preparation under section 503A.
Can I get it as an injection?
Not through Summit. The injectable route is not on the FDA’s eligible list.
Does it work for wrinkles or hair?
The human trials are small. One found no objective improvement after laser resurfacing. For hair loss, minoxidil and finasteride have much better evidence.
Is it safe?
Topical use is generally mild, with irritation or allergic reactions possible. Safety of long-term use is not well studied.
Will the rules change?
They might. The FDA plans an advisory committee consultation before the end of February 2027.
Sources
Where this comes from
All retrieved November 10, 2026.
- Randomized trial of topical copper peptide after carbon dioxide laser resurfacing. https://pubmed.ncbi.nlm.nih.gov/16847171/
- Review of the biology and cosmetic uses of GHK-Cu. https://pubmed.ncbi.nlm.nih.gov/26236730/
- 2026 systematic review on microneedle approaches. https://pubmed.ncbi.nlm.nih.gov/42787770/
- FDA. Bulk drug substances nominated for use in compounding under section 503A: categories list, updated May 14, 2026. https://www.fda.gov/media/94155/download
Confirm with your provider. This page is general education, not medical advice, and it does not diagnose or treat anything. Every medication carries risks and is not right for everyone. Medication is prescribed only after a physician evaluation determines it is appropriate for you. Individual results vary and no outcome is guaranteed. Information current as of November 10, 2026.
Next step
Start with a physician evaluation
Dr. Miranda reviews your history, medications and goals before any decision about GHK-Cu.